En Español

AMYGDALIN
MONOGRAPHIC ANALYSIS


 

Edited by:
DR. JOSE ERNESTO CONTRERAS PULIDO


Clinical Research of the
Hospital Ernesto Contreras R.
Playas de Tijuana, B.C.N.

1963 -1994

Endowed by:
KEMSA LABORATORIES

Playas de Tijuana, B.C.N.

Mexico

These pages or any portion thereof may not be reproduced without the express
written consent of Worldwithoutcancer.org.uk and/or the Oasis Of Hope Hospital.
 

LIST OF AUTHORS

DR. ERNESTO CONTRERAS RODRIGUEZ, M.D.
Chief Director and Founder of the Centro Medico y Hospital Del Mar

Playas de Tijuana, Baja California Norte, Mexico

DR. ABEL MELLADO PRINCE, M.D.
Medical Director of the Centro Medico y Hospital Del Mar

Playas de Tijuana, Baja California Norte, Mexico

DR. JOSE ERNESTO CONTRERAS PULIDO, M.D
Medical Oncologist and Radiation Oncologist of the Centro Medico y

Hospital de Tijuana, Baja Cab fornia Norte, Mexico

Medical Director of KEMSA Laboratories

Playas de Tijuana, Baja California Norte, Mexico

DR. SALVADOR RUBlO VELIZ, M.D.
Neurologist of the Centro Medico y Hospital Del Mar

Playas de Tijuana, Baja California Norte, Mexico

DR. LUIS COTA ALVAREZ
Dr. of Veterinary Medicine and Technical Zoologist of KEMSA Labs

Playas de Tijuana, Baja California Norte, Mexico

OFB. PETRA BELTRAN CORONA
Chief of the Production Department of KEMSA Labs

Playas de Tijuana, Baja California Norte, Mexico

QFB. MARTHA NAVARRETE DEL RIO
Chief of the Quality Control Department of KEMSA Labs

Playas de Tijuana, Baja California Norte, Mexico

DR. KANEMATSU SUGIURA, M.D.
Researcher of the Sloan-Kettering Institute for Cancer Research

New York, U.S.A.

DR. HAROLD MANNER
Director of Research of the Department of Biology

Loyola University, Chicago, Illinois

The remaining authors and studies were endowed by the
McNaughton Foundation, Sausalito, California.

 

TABLE OF CONTENTS


FOREWORD

   

INTRODUCTION

 

SOURCES AND METHODS FOR OBTAINING AMYGDALIN

 

PHYSICAL AND CHEMICAL CHARACTERISTICS

 

PURITY CONTROL TEST FOR AMYGDALIN

 

AMYGDALIN STABILITY TEST

 

ANIMAL TOXICITY STUDIES

   

PRECLINICAL ANTI-TUMOR STUDIES

   

INTRODUCTION TO CLINICAL STUDIES

 

PHASE I STUDY OF TOXICITY IN HUMANS

   

PHASE II STUDY OF ANTITUMORAL EFFECT IN HUMANS

 

PHASE II STUDY OF MULTIFORM GLIOBLASTOMA

 

PHASE III STUDY OF INOPERABLE LUNG CANCER

 

Introduction
Important Warning
About Vitamin B17
Vitamin B17 as Preventative
Metabolic Therapy in Cancer
B17 in Metabolic Therapy
Laetrile and Cyanide
Graphic on Action of B17
Frequently Asked Questions
B17 Therapy components
Accessory Supplements
B17 Therapy Overview
Therapies and Protocols
What is in B17 Therapy?
Maintenance Dosages
Accessory Therapies
Positive Thinking
Implementing Changes
Behaviour of tumours
Criteria for Evaluation
B17 - Sickle Cell Anaemia
Fluoridation-linked Cancer
Contacts
In God We Trust
References

More Studies, Research,

Documented Evidence







©Copyright 2000 - Worldwithoutcancer.org.uk - PO Box 2038 - Leigh-on-Sea - SS9 2ZB - UK
Disclaimer About Us Products Contact Us
Home